In recent years, Chinese healthcare alcohol industry has been developing rapidly. According to data from the China Alcoholic Drinks Industry Association, during the period of 2001-2017, it developed at a rapid CAGR of 26.1%. By 2018, the market size of China’s healthcare wine industry exceeded RMB 40 billion yuan (USD $5.84 billion). In terms of current market share, Jingpai has achieved annual sales of RMB 10.49 billion yuan (USD$ 1.53 billion) in 2017, accounting for one-third of the market share of the entire Chinese healthcare alcohol industry.

Many liquor giants and pharmaceutical companies have also entered the health liquor market, such as Kweichou Maotai, Wuliangye Yibin, Golden Seed, GuangYuYuan, Jiangzhong Pharmaceutical, etc. With the influx of first-line liquor enterprises, regional leaders and pharmaceutical companies, the healthcare alcohol industry has entered a chaotic situation, with increasingly fierce competition and a rapidly changing market landscape. (Source: fangtanchina)

Comments are closed.